Tag: Circa

Circa’s biobased levoglucosenone derivative used in new manufacturing method

Circa’s biobased levoglucosenone derivative used in new manufacturing method

June 13, 2022 |

In Norway, Circa Group AS announced that its levoglucosenone derivative, made from waste, non-food biomass, has been used as an intermediate in an award-winning manufacture process for an investigational drug for leukaemia. The 2022 Peter J. Dunn Award for Green Chemistry and Engineering Impact in the Pharmaceutical Industry recognised MSD for their work in developing […]

Read More

Circa and Valmet to team on ReSolute project and future plants

Circa and Valmet to team on ReSolute project and future plants

May 30, 2022 |

In Norway, Circa and Valmet have signed a Heads of Agreement to realize and optimize the Furacell production process at scale through the ReSolute project and future large-scale plants. Valmet will be the main process technology and equipment supplier, and actively contribute to accelerating the development of Circa’s large-scale production plants. The cooperation considerably strengthens […]

Read More

Circa gets EU green light to import or manufacture its bio-based solvent

Circa gets EU green light to import or manufacture its bio-based solvent

December 11, 2018 |

In the UK, biotechnology company Circa Group has received authorization from the European Chemicals Agency (ECHA) to manufacture or import up to 100 metric tons/year of its bio-based solvent CyreneTM in the European Union, after receiving REACH Annex VIII approval. A chiral dipolar aprotic solvent, CyreneTM was developed in conjunction with the Green Chemistry Centre of Excellence […]

Read More